Koya Medical is a transformative healthcare company developing breakthrough treatments for lymphedema and venous diseases to increase movement, mobility and personalized care that is unavailable with traditional compression therapy.
Koya was founded in 2018 with the mission to transform lymphatic and vein care through innovative patient-centric platforms. We are privately held and proudly located in Oakland, California where we design, develop and manufacture our products.
Interested in joining our team? Email us at info@koyamedical.com.
Koya was founded in 2018 with the mission to transform lymphatic and vein care through innovative patient-centric platforms. We are privately held and proudly located in Oakland, California where we design, develop and manufacture our products.
Interested in joining our team? Email us at info@koyamedical.com.
Location: United States, California, Oakland
Employees: 11-50
Total raised: $67M
Founded date: 2018
Investors 2
| Date | Name | Website |
| - | 3x5 Partne... | 3x5partner... |
| 18.11.2023 | OrbiMed | orbimed.co... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 15.11.2023 | - | $30M | - |
| 03.02.2022 | Series B | $26M | - |
| 14.01.2021 | Series A | $11M | - |
Mentions in press and media 13
| Date | Title | Description |
| 15.11.2023 | Koya Medical Raises Up To $30M in Financing | Koya Medical, an Oakland, CA-based healthcare company, raised up to $30M in funding. The round was led by OrbiMed. The company intends to use the funds to support its strategic expansion and continued growth. Led by CEO Andy Doraiswamy, Koy... |
| 04.02.2022 | Koya Medical picks up $26M Series B | Koya Medical has raised a $26 million round led by 3x5 Partners, with support from Asahi Kasei Ventures and Cadence Healthcare Ventures. Founded in 2018, the Oakland, Calif.-based company is a developer of therapeutics for lymphedema and ve... |
| 04.02.2022 | Koya Medical raises $26M for its wearable lymphedema therapeutic | Lymphedema, a build-up of fluid due a blocked lymph system, affects 20 million people annually You may not have heard of lymphedema, but there's a decent chance you know someone who has it: an estimated 20 million Americans live with the di... |
| 03.02.2022 | Koya Medical Raises $26M in Series B Funding | Koya Medical, an Oakland, Calif.-based healthcare company focused on advancing lymphatic and venous care through a comprehensive suite of people-centric platforms, closed a $26m Series B financing. The round was led by 3×5 Partners, along w... |
| 03.02.2022 | Koya Medical Scoops Up $26M Series B | OAKLAND, CA, Koya Medical today announced the close of a $26 million Series B financing. >> Click here for more funding data on Koya Medical >> To export Koya Medical funding data to PDF and Excel, click here Koya Medical... |
| 03.02.2022 | Koya Medical Secures $26M in Series B Funding to Advance Portfolio of Active Compression Therapies for Lymphedema and Venous Disorders | Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, today announced the close of a $26 million Series B financing. The round was led b... |
| 11.10.2021 | Koya Medical : Presents Positive Interim Data from Randomized Trial Comparing its Dayspring Lymphedema Treatment to Pneumatic Compression | Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, recently presented data from the company’s prospective, multi-center, randomized, ... |
| 28.09.2021 | Koya Medical : Receives FDA Clearance for Dayspring Lite, Bringing Much-Needed Movement to People Beginning Compression Therapy to Treat Lymphedema and Venous Disease | Koya Medical, a healthcare company on a mission to transform lymphatic and venous care through a comprehensive suite of innovative, people-centric platforms, received Food and Drug Administration (FDA) 510(k) clearance for its Dayspring® Li... |
| 10.08.2021 | Koya Medical : Secures First Reimbursement Codes for Dayspring, for Lymphedema; Publishes Clinical Data Demonstrating Improved Function, Appearance, Mood and Symptoms | Koya Medical, a healthcare company focused on developing breakthrough treatments for lymphedema and venous diseases, announced today that its wearable, active compression therapy system for lymphedema—Dayspring™— was issued new billing code... |
| 26.05.2021 | Koya Medical Receives FDA Clearance for Indication of First Mobility-Enabled Active Compression for Lower Extremities |
Show more